Skip to content
Open access

Risk stratification in patients with pulmonary metastasis from colorectal cancer: prognostic utility of a composite inflammatory–nutritional index (N-CALLY index) — a retrospective cohort study

Sep 2026 · BMC Cancer · 0 citations

TL;DR

The N-CALLY index may serve as an adjunctive prognostic marker to complement established clinicopathological factors, but should not be used as a stand-alone criterion for pulmonary metastasectomy or other treatment selection.

Abstract

Pulmonary metastasis from colorectal cancer is associated with heterogeneous clinical outcomes, and reliable prognostic markers are needed for individualized risk stratification. The N-CALLY index, defined as the neutrophil-to-lymphocyte ratio (NLR) multiplied by the C-reactive protein-to-albumin ratio (CAR), is a composite marker that integrates two established components of the systemic inflammatory response. This study evaluated its prognostic value in patients who developed pulmonary metastasis after curative resection of primary colorectal cancer. This retrospective single-center study analyzed 76 patients who developed pulmonary metastasis after curative resection of primary colorectal cancer between January 2008 and December 2022, after exclusion of one outlier case from an initial cohort of 77 consecutive patients. The N-CALLY index and other inflammatory, nutritional, and skeletal muscle indices were measured at the time of pulmonary metastasis diagnosis. Prognostic associations with overall survival were evaluated using receiver operating characteristic (ROC) analysis, Kaplan-Meier survival analysis, and Cox proportional hazards regression. Exploratory prognostic models with and without the N-CALLY index were compared using time-dependent ROC analysis and concordance indices. The N-CALLY index showed the highest area under the ROC curve among the systemic inflammatory and nutritional indices examined (AUC = 0.628), with a cohort-derived cut-off value of 0.03. An elevated N-CALLY index (≥ 0.03) was significantly associated with worse overall survival in univariate analysis (hazard ratio [HR], 3.524; 95% confidence interval [CI], 1.536–8.084; p  = 0.003) and remained independently associated with worse overall survival in multivariable analysis (HR, 3.014; 95% CI, 1.285–7.068; p  = 0.011). The prognostic model including the N-CALLY index showed higher time-dependent AUC values for 1-, 3-, and 5-year overall survival than the model without the N-CALLY index (0.730 vs. 0.619, 0.771 vs. 0.705, and 0.758 vs. 0.721, respectively), and the apparent C-index increased from 0.662 to 0.708 (optimism-corrected C-index, 0.645 to 0.686). An elevated N-CALLY index at the time of pulmonary metastasis diagnosis was independently associated with worse overall survival, and its addition to a clinical prognostic model was associated with improved discrimination in this exploratory cohort. The N-CALLY index may therefore serve as an adjunctive prognostic marker to complement established clinicopathological factors, but should not be used as a stand-alone criterion for pulmonary metastasectomy or other treatment selection. Validation in independent external cohorts is required before clinical application.

Read PDF

Similar papers

Open access Sep 2026

The Prognostic Value of the Advanced Lung Cancer Inflammation Index on Disease-Free Survival in Patients with Gastric Cancer Receiving Neoadjuvant Chemotherapy

A low pre-treatment ALI score independently predicts shorter DFS in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy and surgery, warranting further prospective validation.

Mahmut Kara, Muslih Ürün, S. Ebinç et al. · 0 citations
Open access Oct 2026

Clinical utility of combining the C-reactive protein-to-albumin ratio and systemic immune-inflammation index for prognostic assessment in metastatic renal cell carcinoma

Background Inflammation-based biomarkers may refine prognostic stratification in patients with metastatic renal cell carcinoma (mRCC). This study evaluated the prognostic value of the pretreatment C-reactive protein-to-albumin ratio (CAR) and systemic immune-inflammation index (SII) in patients with mRCC receiving firs...

N. Muramoto, Masayoshi Nagata, Hisashi Hirano et al. · 0 citations
Open access Sep 2026

Differential Prognostic Associations of Monocyte-Containing and Traditional Systemic Inflammatory Indices with Overall Survival After Resection or Palliative Bypass for Pancreatic Cancer: A Retrospective Cohort Study

AISI and SIRI showed statistical heterogeneity in their associations with overall survival between operative groups, with higher values associated with mortality following palliative bypass, with higher values associated with mortality following palliative bypass.

Rares Voda, Sohaib Ahmed, O. Budișcă et al. · 0 citations
Open access Sep 2026

Prognostic Value of the Postoperative Advanced Lung Cancer Inflammation Index in Patients with Prostate Cancer Undergoing Radical Prostatectomy

Objective This study investigated whether the postoperative advanced lung cancer inflammation index (ALI) has prognostic significance in patients with prostate cancer who underwent radical prostatectomy. It also explored the potential role of ALI as a biomarker for assessing postoperative recurrence risk. Patients and...

Guo-Ping Xie, R. Kang, Dan Chen et al. · 0 citations
Open access Sep 2026

Association between the preoperative C-reactive protein-albumin-lymphocyte index and prognosis after hepatic resection for hepatocellular carcinoma

The preoperative CALLY index was independently associated with DFS and OS after hepatic resection for primary HCC and may help identify patients at a high risk of recurrence and poor survival.

Tomonari Shimagaki, Atsushi Maeda, T. Harima et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.